Download The Article
Recent Advances in OA Treatment: Disease-Modifying Osteoarthritis Drugs
Recent Advances in OA Treatment: Disease-Modifying Osteoarthritis Drugs
Article:
Redefining Osteoarthritis Clinical Development
The Emerging Role of DMOADs
Disease-modifying osteoarthritis drugs (DMOADs) represent a new pharmacological approach to disease management with the potential to not only relieve pain, but also slow disease progression or even reverse damage that has already occurred, offering new hope to both treating physicians and their patients.
Download this article to explore recent advances in OA treatment, the complexities of DMOAD trials, and strategic approaches for clinical success.
Leading Rheumatology CRO
Streamlining Clinical Research in Rheumatology
Medpace’s expertise and consistent track record of success as a full-service CRO across various therapeutic areas provides the flexibility necessary to meet the unique needs of rheumatology research. Our in-house board-certified rheumatologists have a thorough understanding of the complex conditions that cause these diseases, as well as the medical complications experienced by patients. Experts collaborate across therapeutic areas to create effective and efficient study designs for Sponsors of all sizes.